Loading the company…
Loading the company…
No clearances or recalls under the mapped product codes.
All companies · Product and company coverage
In the last ten years FDA made 6 decisions for Trilliant Surgical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 0 procedure families, the most in 2017 (3). The latest was on 2022-02-23.
In 2025, Trilliant Surgical reported engagement with 175 surgeons and other clinicians in the states MedaRep covers, worth $396K in consulting, speaking, meals and travel for its device products, the most in Illinois ($68K to 5). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Illinois ($68K, 5 engaged), California ($64K, 19 engaged), North Carolina ($51K, 2 engaged), Texas ($40K, 26 engaged), Iowa ($28K, 1 engaged).
| Minimally Invasive Bunion Plating System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Trilliant Surgical.